SANE Vax Inc. Discovers Potential Bio-hazard Contaminant in Merck’s Gardasil™ HPV 4 Vaccine | SaneVax
SANE Vax Inc. Discovers Potential Bio-hazard Contaminant in Merck’s Gardasil™ HPV 4 Vaccine | SaneVax. 100% of vials tested from New Zealand, Australia, Spain, Poland, France and three states in the U.S. contained genetically modified HPV Recombinant DNA from HPV-11 and HPV-18. These contaminants were firmly attached to aluminum adjuvants, which result in the DNA persisting in the blood for years after vaccination. Commissioner Hamburg has been notified so that appropriate action can be taken to protect public safety.
Merck’s Gardasil Patient Product Inserts states that the vaccine contains “no viral DNA” in the Gardasil vaccine, indicating that it was known to be an undesirable component, and therefore required assurances of its absence. That assurance was removed from the product insert in April 2011, indicating some possible knowledge by the company that it had been detected, yet no measures were taken to notify the public or suspend distribution until the product could be tested and assured of purity and safety.
This contamination would not have been revealed but for independent laboratory testing. The results of this research underscores the need for independent research funded by foundations and philanthropists with no financial ties to the drug industry. Conflicting and competing financial interests prevent patient safety from being the highest priority of our FDA and related health agencies.